Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Duane Luttrell v. Novartis Pharmaceuticals Corp.
Case Number:
12-35893
Court:
Nature of Suit:
4365 Personal Injury-Product Liability
Companies
Sectors & Industries:
-
February 20, 2014
9th Circ. Refuses To Revive Novartis Jaw Injury Suit
A Ninth Circuit panel on Thursday refused to revive a product liability lawsuit against Novartis Pharmaceuticals Corp. over jaw injuries allegedly related to bone drugs Aredia and Zometa, ruling that the plaintiff continued the drugs after his injury and could not prove they caused it.
-
February 04, 2014
9th Circ. Urged To Reinstate Expert In Novartis Jaw Injury Suit
Two former users of Novartis Pharmaceuticals Corp. bone drugs Aredia and Zometa urged the Ninth Circuit on Monday to allow expert testimony that the medications caused their jaw injuries and to revive their lawsuits against the drugmaker.